HomeCompareCRWRF vs PLD

CRWRF vs PLD: Dividend Comparison 2026

CRWRF yields 1.84% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $5.88M in total portfolio value
10 years
CRWRF
CRWRF
● Live price
1.84%
Share price
$24.20
Annual div
$0.44
5Y div CAGR
12%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.9K
Annual income
$702.06
Full CRWRF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — CRWRF vs PLD

📍 PLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRWRFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRWRF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRWRF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRWRF
Annual income on $10K today (after 15% tax)
$156.23/yr
After 10yr DRIP, annual income (after tax)
$596.75/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, PLD beats the other by $4,037,519.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRWRF + PLD for your $10,000?

CRWRF: 50%PLD: 50%
100% PLD50/50100% CRWRF
Portfolio after 10yr
$2.97M
Annual income
$2,375,713.62/yr
Blended yield
80.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CRWRF
No analyst data
Altman Z
4.6
Piotroski
7/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRWRF buys
0
PLD buys
0
No recent congressional trades found for CRWRF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRWRFPLD
Forward yield1.84%3.10%
Annual dividend / share$0.44$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR12%74.4%
Portfolio after 10y$24.9K$5.91M
Annual income after 10y$702.06$4,750,725.19
Total dividends collected$4.1K$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CRWRF vs PLD ($10,000, DRIP)

YearCRWRF PortfolioCRWRF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$10,906$205.86$11,241$540.96$335.00PLD
2$11,904$235.00$13,019$991.13$1.1KPLD
3$13,006$268.50$15,801$1,870.97$2.8KPLD
4$14,224$307.05$20,609$3,701.21$6.4KPLD
5$15,571$351.49$29,919$7,867.97$14.3KPLD
6$17,063$402.76$50,631$18,617.74$33.6KPLD
7$18,720$462.00$105,528$51,352.20$86.8KPLD
8$20,561$530.53$287,364$174,449.42$266.8KPLD
9$22,610$609.93$1,081,760$774,280.77$1.06MPLD
10$24,895$702.06$5,908,209$4,750,725.19$5.88MPLD

CRWRF vs PLD: Complete Analysis 2026

CRWRFStock

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers InSight Denials to analyze, track, trend, and report on denial data; Trisus Healthcare Intelligence, a solution that provides insights into resource consumption on the patient level; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentrex 330; Referral Verification System; and Sentry Core, a solution that simplifies the complexities of pharmacy procurement, utilization, and compliances. Further, it offers appeal and professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Full CRWRF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this CRWRF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRWRF vs SCHDCRWRF vs JEPICRWRF vs OCRWRF vs KOCRWRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.